Manhattan Associates 주식 (NASDAQ: MANH)

에 대한 최신 뉴스 Manhattan Associates (NASDAQ:MANH) 주식

Manhattan Associates

Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.

News

Movers

AVTR

CBRE

ENPH

FCNCA

LPLA

MANH

SIRI

SPOT

이들 11개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? QXO(NASDAQ:QXO)의 주가는 사모 금융 유치를 발표한 이후 33.37% 상승했다.

유니버셜 헬스 및 록히드 마틴은 지난주 최고 성과를 보여준 11개 대형주 중 일부 (7월 21일-7월 27일)

Large Cap

Price Target

New Oriental Education & Technology Group

MSCI

실적 시즌이 본격화되면서 이들 10개 대형주는 지난주 최악의 실적을 기록했다. 그것들이 당신의 포트폴리오에 있나요? LKQ 코퍼레이션(NASDAQ:LKQ) 주가가 1분기 실적 부진 및 2024년도 전망 하향 조정 발표 이후 12.3% 급락했다.

지난주 최하 성과 주식: 이 10개의 대형주가 포트폴리오에 있나요? (4월 21일-27일)

Manhattan Associates, Inc. - Common Stock

Manhattan Associates Inc

Manhattan Bridge Capital, Inc - Common Stock

Manhattan Bridge Capital Inc

Manhattan Corp Ltd

MANHATTAN SCIENTIFICS INC by Manhattan Scientifics, Inc.

Manhattan Scientifics Inc

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 15 years by 18.87% on an annualized basis producing an average annual return of 30.89%. Currently, Manhattan Associates has a market capitalization of $17.52 billion. 
Buying $100 In MANH: If an investor had bought $100 of MANH stock 15 years ago, it would be worth $5,582.18 today based on a price of $286.00 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727292635_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Manhattan Associates 15 Years Ago Would Be Worth This Much Today

Citigroup analyst George Kurosawa maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Neutral and raises the price target from $257 to $287.

Analyst Ratings

Citigroup Maintains Neutral on Manhattan Associates, Raises Price Target to $287

TELUS Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tu#NYSE">TU</a>) is set to launch SmartEnergy, a unique solution designed to help customers save on energy bills and minimize their environmental impact, all through an easy-to-use app that offers attractive incentives on smart devices. This service is now accessible to all Canadians outside Quebec for C$12 per month, and new subscribers can get a smart thermostat and two smart plugs for a one-time fee of C$25, saving over C$250.
The SmartHome+ app leverages AI and real-time insights to help users automate their daily routines, track energy consumption and control all connected devices &mdash; new and existing &mdash; from one convenient interface, added TELUS.
Using TELUS&#39; SmartHome+ app, subscribers can connect compatible smart devices like thermostats and plugs to save up to 15% on energy bills through automated temperature adjustments, switching off unused devices and personalized routines. They can also monitor their energy consumption with insights over various periods, along with tips for maximizing savings. Additionally, subscribers can participate in energy-saving events that ease the load on the energy grid during peak times by automatically powering down devices or adjusting thermostat settings, all while earning TELUS Rewards for their contributions to sustainability.
TELUS plans to further expand the range of smart devices compatible with the SmartHome+ app to include EV chargers and home solar systems, enabling customers to access more savings while managing their home automation, security and Internet services easily. The company is also collaborating with Canadian utilities to support grid demand response programs, which are essential during extreme weather conditions that increase demand and may lead to shortages or outages.
<div class="chart_embed">
<h3>TELUS Corporation Price and Consensus</h3>
<img alt="TELUS Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/6a/1726755546.png" style="height:265px; width:574px" title="" />
TELUS Corporation price-consensus-chart | TELUS Corporation Quote
</div>
<h2>TELUS Focused on Driving Sustainability &nbsp;</h2>
TELUS actively supports environmental sustainability and is planting four trees annually for each SmartEnergy subscriber. Over the last two decades, the company has planted a total of 12.7 million trees and has remained dedicated to restoring forests for the benefit of both present and future generations.
The company aims to source 100% of its electricity from renewable or low-emission sources by 2025 and enhance energy efficiency by 50% by 2030 compared to 2019 levels. Its goal is to become a net carbon-neutral company by 2030 or sooner.
Earlier this month, the company joined forces with the Quebec Artificial Intelligence Institute, Mila, to advance artificial intelligence technology for societal good. This partnership will allow both organizations to explore cutting-edge AI innovations and assess their potential effects on various industries, benefiting customers in Canada. TELUS also holds the Outstanding Organization prize from the Responsible AI Institute for its dedication to fostering trust and benefiting society.
Vancouver, British Columbia-based TELUS is one of the leading telecom carriers in Canada (the largest in western Canada), with more than C$20 billion in annual revenues and 19 million customer connections. It provides wireless, wireline and Internet communications services for voice and data to businesses and consumers.
<h2>TU&#39;s Zacks Rank &amp; Stock Price Performance</h2>
TU currently carries a Zacks Rank #3 (Hold). Shares of the company have gained 3.3% in the past year compared with the sub-industry&#39;s growth of 7.5%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/41/78493.jpg?v=1170747498" />
Image Source: Zacks Investment Research
<h2>Stocks to Consider</h2>
Some better-ranked stocks from the broader technology space are Manhattan Associates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>), ANSYS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>) and American Software, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amswa#NASDAQ">AMSWA</a>). MANH presently sports a Zacks Rank #1 (Strong Buy), whereas ANSS &amp; AMSWA carry a Zacks Rank #2 (Buy) each.
Manhattan Associates delivered an earnings surprise of 26.6%, on average, in the trailing four quarters. In the last reported quarter, MANH pulled off an earnings surprise of 22.9%. The Zacks Consensus Estimate for MANH has increased 9.2% to $4.26 in the past 60 days.
ANSYS delivered an earnings surprise of 4.8%, on average, in three of the trailing four quarters. In the last reported quarter, ANSS pulled off an earnings surprise of 28.9%. It has a long-term earnings growth expectation of 6.4%.
American Software delivered an earnings surprise of 84.5%, on average, in the trailing four quarters. In the last reported quarter, AMSWA pulled off an earnings surprise of 71.4%. The Zacks Consensus Estimate for AMSWA has increased 8.6% to 38 cents in the past 60 days.
<a href="https://www.zacks.com/stock/news/2338734/telus-unveils-new-smartenergy-solution-to-boost-sustainability?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2338734">To read this article on Zacks.com click here.</a>

Earnings

Small Cap

Markets

Tech

AMSWA

ANSS

TELUS Unveils New SmartEnergy Solution to Boost Sustainability

Manhattan Associates's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NYSE">MANH</a>) short percent of float has risen 17.17% since its last report. The company recently reported that it has 2.10 million shares sold short, which is 4.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Manhattan Associates Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726666225_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Manhattan Associates has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Manhattan Associates's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Manhattan Associates's peer group average for short interest as a percentage of float is 3.21%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Manhattan Associates?

In the last three months, 4 analysts have published ratings on Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), offering a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $273.0, a high estimate of $285.00, and a low estimate of $257.00. Surpassing the previous average price target of $248.75, the current average has increased by 9.75%.
<img src="https://www.benzinga.com/files/images/story/2024/1726513286_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Manhattan Associates by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$285.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$265.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$285.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$257.00</td>
<td>$220.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Manhattan Associates. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Manhattan Associates's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Manhattan Associates's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>About Manhattan Associates</h2>
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>Key Indicators: Manhattan Associates's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Manhattan Associates displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 14.85%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 19.89%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Manhattan Associates's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 21.98%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Manhattan Associates's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 7.88%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.21, Manhattan Associates adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For Manhattan Associates

Loop Capital analyst Mark Schappel maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Buy and raises the price target from $265 to $285.

Loop Capital Maintains Buy on Manhattan Associates, Raises Price Target to $285

SAP SE&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sap#NYSE">SAP</a>) stock is continuing its upward trajectory, with a gain of 36.7% in the year to date compared with 13.3% and 6.2% growth of the S&amp;P 500 composite and the sub-industry, respectively.
The company is currently trading at a nearly 4.5% discount to its 52-week high of $221.24, reached on Aug. 29, 2024. This pullback from the recent peak might offer a strategic buying opportunity for investors looking to capitalize on potential gains.
With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) stock appears to be a solid investment option at the moment.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ca/76992.jpg?v=735422294" />
Image Source: Zacks Investment Research
Apart from a favorable rank, SAP has a VGM Score of B. Per Zacks&#39; proprietary methodology, stocks with a combination of a Zacks Rank #1 (Strong Buy) or 2 and Growth Score of A or B offer solid investment opportunities.
<h2>SAP&#39;s Thriving Cloud Business</h2>
SAP has been concentrating on expanding its cloud business to become one of the leading players in the category. In the last reported quarter, the current cloud backlog &mdash; a key indicator of go-to-market success in cloud business &mdash; soared 28% (both at nominal and cc basis) to &euro;14.8 billion.
Increasing demand for Rise with SAP solution remains the biggest driver. This solution helps companies transform its business processes and operations to become more nimble, digital and intelligent. SAP solution continues to gain significant traction and will aid the company in driving its market share in the cloud ERP solutions space.
Rise with SAP will also help the company boost the uptake of its SAP S/4HANA solution by providing its customers with more options for implementation and support from certified partners. Momentum in other cloud offerings like Grow with SAP and SAP Datasphere, as well as strategic acquisitions and collaborations, bodes well for its cloud business.
In the second quarter of 2024, SAP&#39;s cloud revenues were &euro;4.15 billion, up 25% year over year on a non-IFRS basis (nominal and cc). The uptick resulted from notable 33% growth in Cloud ERP Suite revenues, highlighting the effectiveness of SAP&#39;s Software-as-a-Service (SaaS) and Platform-as-a-Service (PaaS) solutions.
SAP&#39;s cloud business strength was prominent across India, Japan, South Korea, Germany, Brazil and Canada. This business strength also remained strong in the United States, Saudi Arabia and China.
<h2>SAP&#39;s Robust Outlook for Cloud Business</h2>
Given the strong momentum in the cloud business, management anticipates 2024 cloud revenues in the range of &euro;17-&euro;17.3 billion, which indicates an increase of 24-27% at cc on a year-over-year basis. Cloud and software revenues are expected to be between &euro;29 billion and &euro;29.5 billion, respectively, which implies 8-10% growth at cc on a year-over-year basis. 
SAP expects cloud revenues of more than &euro;21.5 billion and total revenues of more than &euro;37.5 billion for 2025.
<h2>SAP Focused on Generative AI</h2>
SAP remains optimistic about the generative AI trend. In April 2024, SAP announced significant advancements in AI for supply chain solutions, aiming to redefine productivity and efficiency in manufacturing sectors. The company announced a collaboration with IBM and Amazon Web Services to make strides in GenAI capabilities and unlock potential business opportunities.
Management announced that it would focus on vital strategic growth areas, especially Business AI and position the company for growth, earlier in 2024. SAP intensified its restructuring efforts, expecting total expenses of roughly &euro;3 billion. This initiative is crucial for aligning SAP&#39;s workforce and resources with long-term business strategies.
Nonetheless, softness in the Software license and support business segment coupled with global macroeconomic weakness are concerning. Increasing costs and stiff competition in the cloud space are additional headwinds.
<h3>SAP&#39;s Estimates Northbound</h3>
The Zacks Consensus Estimate for SAP&#39;s 2024 and 2025 revenues is pegged at $36.7 billion and $40.6 billion, respectively, which indicates growth of 8.8% and 10.6% from the year-ago levels.
The consensus estimate for 2024 EPS is pegged at $4.83. For 2025 EPS, the consensus estimate is anticipated at $6.33, implying a rise of 31.2 % from the prior-year actual.
The Zacks Consensus Estimate for 2024 and 2025 EPS has increased 5% and 3.3%, respectively, in the past 60 days, reflecting analysts&#39; optimism.
<h2>Other Stocks to Consider</h2>
Some other top-ranked stocks worth consideration in the broader technology space are Manhattan Associates (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>), Adobe (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) and ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>). While Manhattan Associates sports a Zacks Rank #1, Adobe and ANSYS carry a Zacks Rank #2 each, at present.
The Zacks Consensus Estimate for Adobe&#39;s fiscal 2024 EPS is pegged at $18.16, unchanged in the past 30 days. ADBE&#39;s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 2.7%. The long-term earnings growth rate is 13%. Its shares have declined 0.2% in the past year.
The Zacks Consensus Estimate for ANSS&#39; 2024 earnings is pegged at $9.96, unchanged in the past 30 days. ANSS&#39; earnings beat the Zacks Consensus Estimate in three of the last four quarters while missing the mark once, with the average surprise being 4.8%. Its shares have declined 3.2% in the past year.
The Zacks Consensus Estimate for MANH&#39;s 2024 EPS is pegged at $4.26, unchanged in the past 30 days. MANH&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 26.6%. The stock has surged 23.4% in the past year.
<a href="https://www.zacks.com/stock/news/2333400/sap-stock-surges-37-year-to-date-will-the-rally-continue?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2333400">To read this article on Zacks.com click here.</a>

Earnings Beats

Offerings

Management

ADBE

SAP Stock Surges 37% Year to Date: Will the Rally Continue?

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 10 years by 12.44% on an annualized basis producing an average annual return of 22.96%. Currently, Manhattan Associates has a market capitalization of $15.35 billion. 
Buying $100 In MANH: If an investor had bought $100 of MANH stock 10 years ago, it would be worth $818.43 today based on a price of $250.66 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725897616_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have $800 Today

Ciena Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cien#NYSE">CIEN</a>) and Arelion have achieved a milestone with the world&#39;s first 1.6 terabits-per-second (Tb/s) wavelength data transmission in a live network field trial. Utilizing Ciena&#39;s advanced WaveLogic 6 Extreme (WL6e), this achievement took place over Arelion&#39;s 470km route connecting its Ashburn, Virginia (Equinix) and Telxius&#39; Virginia Beach cable landing station. This success has significantly boosted capacity between these key Points-of-Presence (PoPs) in Arelion&#39;s North American network.
Arelion addresses connectivity issues for multinational enterprises dependent on digital infrastructure across the globe. It offers IP services for unlimited global Internet access and provides enterprise, networking, and mobile data solutions to connect critical content and applications to audiences worldwide.
This data transmission boosts the performance of Arelion&#39;s leading optical transmission services, including high-speed Managed Optical Fiber Services and Wavelengths for service providers, content providers as well as enterprises. Following its recent trial, Arelion will deploy Ciena&#39;s WL6e across its network to meet the growing bandwidth demands of 5G, AI/ML applications, cloud services, and content delivery for wholesale and enterprise customers.
The use of coherent digital signal processing innovations boosts energy performance and efficiency for WL6e. It offers Arelion a 50% reduction in space and power per bit, along with a 15% improvement in spectral efficiency compared to previous generations, added CIEN. With WL6e, Arelion can provide multiple 400 and 800 gigabits-per-second (Gb/s) services, leveraging 1.6 Tb/s line capacity to support higher traffic volumes and faster connectivity speed across its existing network.
Ciena&#39;s open, programmable 6500 Reconfigurable Line System (&quot;RLS&quot;) was also utilized in the demonstration. RLS simplifies and automates network service provisioning and reconfiguration. Together, these innovations reinforce Arelion&#39;s commitment to open optical networking and next-generation coherent optic solutions, driving improvements in performance, energy efficiency and cost savings.
<div class="chart_embed">
<h3>Ciena Corporation Price and Consensus</h3>
<img alt="Ciena Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/ad/1725026395.png" style="height:265px; width:574px" title="" />
Ciena Corporation price-consensus-chart | Ciena Corporation Quote
As the industry&#39;s first 1.6 Tb/s coherent optic solution, Ciena&#39;s WaveLogic 6 Extreme introduces cutting-edge capabilities for optical transport. With Arelion at the forefront, this milestone sets a benchmark for other service providers aiming to enhance energy efficiency and scalability in their optical networks to meet rising bandwidth demands, added Ciena.
</div>
Ciena is one of the leading providers of optical and routing systems, services and automation software worldwide. It builds highly adaptive networks to meet increasing digital demands and deliver richer, more connected user experiences.
Ciena&#39;s revenues for the second quarter of fiscal 2024 decreased 19.6% year over year, totaling $910.8 million. This decline was due to a slower-than-expected recovery of order volumes from service providers who are still working through large inventory absorption.
Nonetheless, demand for bandwidth remained strong owing to higher cloud adoption and the proliferation of AI technology use cases.
<h2>CIEN&#39;S Zacks Rank &amp; Stock Price Performance</h2>
CIEN currently carries a Zacks Rank #3 (Hold). Shares of the company have risen 13.5% in the past year compared with the sub-industry&#39;s growth of 13.2%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/38/76131.jpg?v=1702104680" /> 
Image Source: Zacks Investment Research
<h2>Stocks to Consider&nbsp;</h2>
Some better-ranked stocks from the broader technology space are Manhattan Associates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>), ANSYS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>) and Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>).&nbsp; MANH presently sports a Zacks Rank #1 (Strong Buy), while ANSS and ADBE carry a Zacks Rank #2 (Buy) each.
Manhattan Associates delivered an average earnings surprise of 26.6% in the trailing four quarters. In the last reported quarter, MANH pulled off an earnings surprise of 22.9%. The Zacks Consensus Estimate for 2024 earnings has increased 9.2% in the past 60 days to $4.26.
ANSYS delivered a trailing four-quarter average earnings surprise of 4.8%. In the last reported quarter, ANSS pulled off an earnings surprise of 28.9%. It has a long-term earnings growth expectation of 6.4%.
Adobe delivered a trailing four-quarter average earnings surprise of 2.7%. In the last reported quarter, ADBE pulled off an earnings surprise of 2.1%. It has a long-term earnings growth expectation of 13%.
<a href="https://www.zacks.com/stock/news/2329685/ciena-arelion-reach-live-1-6-tb-s-wave-data-transmission-milestone?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2329685">To read this article on Zacks.com click here.</a>

Mid Cap

CIEN

Ciena & Arelion Reach Live 1.6 Tb/s Wave Data Transmission Milestone

NetApp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntap#NASDAQ">NTAP</a>) has introduced new capabilities to bolster VMware Cloud Foundation deployments. These enhancements will allow mutual customers to optimize their IT environments for efficient scaling of VMware workloads.
These offerings are built on last month&#39;s enhancements to NetApp BlueXP disaster recovery service, which now includes guided workflows for automating disaster recovery plans for VMware workloads in hybrid cloud environments, with new support for VMFS datastores.
Customers of both NetApp and Broadcom can now simplify VCF hybrid cloud environments with NetApp ONTAP software. It will also support all storage needs and incorporate SnapMirror active sync for enhanced data replication and availability. For those migrating to the cloud, NetApp&#39;s Spot Eco with Azure VMware Solution (AVS) reserved instances and Azure NetApp Files offer significant cost savings. Additionally, the expanded Cloud Insights VM Optimization features help reduce costs, improve VM density and ensure optimal performance and adherence to configuration.
For more than a decade, NetApp has been a key engineering design partner with VMware, recently acquired by Broadcom Inc. The company continues to drive innovation in highly available, scalable and performant storage as a design partner for VMware&#39;s Next-Generation vSphere Virtual Volumes.
NetApp and Broadcom joined forces to eliminate uncertainty in hybrid cloud environments. With more than 20,000 customers depending on NetApp for VMware workload support, NetApp emphasized that its ongoing collaboration with Broadcom, following VMware&#39;s acquisition, guarantees seamless integration of their solutions. This ensures that mutual customers can efficiently utilize a unified, &quot;intelligent data infrastructure&quot; for their VMware operations.
<div class="chart_embed">
<h3>NetApp, Inc. Price and Consensus</h3>
<img alt="NetApp, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/e6/1724940372.png" style="height:265px; width:581px" title="" />
NetApp, Inc. price-consensus-chart | NetApp, Inc. Quote
This collaboration with NetApp also enables their mutual customers to deploy cutting-edge data and storage services on their private cloud platforms, ensuring they maximize the value of their VMware environments, Broadcom added.
Based in San Jose, CA, NetApp provides enterprise storage as well as data management software and hardware products and services.
The company recently reported first-quarter fiscal 2025 revenues of $1.54 billion, marking an 8% year-over-year increase and exceeding the Zacks Consensus Estimate by 0.46%. This growth was driven by a 40% year-over-year surge in revenues from first-party and marketplace cloud storage services. The company also reported non-GAAP earnings of $1.56 per share, up 35.7% and surpassing the Zacks Consensus Estimate of $1.46.
</div>
<h2>NTAP&#39;S Zacks Rank &amp; Stock Price Performance</h2>
Currently, NTAP carries a Zacks Rank #2 (Buy). Shares of the company have gained 72.5% compared with the sub-industry&#39;s growth of 55.9%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/7a/75964.jpg?v=1229461314" />
Image Source: Zacks Investment Research
<h2>Other Stocks to Consider</h2>
Some other top-ranked stocks from the broader technology space are Manhattan Associates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>), ANSYS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>) and Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>).&nbsp;MANH presently sports a Zacks Rank #1 (Strong Buy) each, whereas ANSS &amp; ADBE carry a Zacks Rank #2.
Manhattan Associates delivered an earnings surprise of 26.6%, on average, in the trailing four quarters. In the last reported quarter, MANH pulled off an earnings surprise of 22.9%. The Zacks Consensus Estimate for MANH increased 9.2% in the past 60 days to $4.26.
ANSYS delivered an earnings surprise of 4.8%, on average, in three of the trailing four quarters. In the last reported quarter, ANSS pulled off an earnings surprise of 28.9%. It has a long-term earnings growth expectation of 6.4%.
Adobe delivered an earnings surprise of 2.7%, on average, in the trailing four quarters. In the last reported quarter, ADBE pulled off an earnings surprise of 2.1%. It has a long-term earnings growth expectation of 13%.
<a href="https://www.zacks.com/stock/news/2329115/netapp-unveils-capabilities-to-enhance-vmware-cloud-deployments?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2329115">To read this article on Zacks.com click here.</a>

NTAP

NetApp Unveils Capabilities to Enhance VMware Cloud Deployments

Simulations Plus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slp#NASDAQ">SLP</a>) has streamlined its business unit and leadership structure to foster growth after recent acquisitions. These updates will be implemented on Aug 30, 2024.
Over the past year, Simulations Plus made two major acquisitions, including the largest in its corporate history. In June 2024, the company acquired Pro-ficiency Holdings, Inc. and its subsidiaries from QHP Capital and its minority shareholders for about $100 million, expanding its footprint across the drug development continuum, from pre-clinical protocols to product commercialization. This acquisition doubled Simulations Plus&#39; addressable market by adding $4 billion in revenue opportunities within the clinical simulations training, analytics and medical communications sectors.
Building on this recent acquisition, Simulations Plus is focusing on optimizing its resources and people. The company is establishing two new business units &mdash; Adaptive Learning &amp; Insights and Medical Communications &mdash; to improve client engagement. Additionally, the Regulatory Strategies unit will transition into a Regulatory Strategies Center of Excellence to enhance sales visibility and accelerate cross-selling opportunities.
These strategic moves aim to strengthen Simulations Plus&#39; position across the drug development continuum, driving growth and profitability, the company added.
Simulations Plus announced key leadership promotions. Steven Chang is elevated to president of Quantitative Systems Pharmacology following his arrival with the Immunetrics acquisition in June 2023. Jenna Rouse will lead the new Adaptive Learning &amp; Insights unit as president, having served as chief markets officer, Clinical, at Pro-ficiency. Murry Alper will become president of the new Medical Communications unit, also joining through the Pro-ficiency acquisition.
<div class="chart_embed">
<h3>Simulations Plus, Inc. Price and Consensus</h3>
<img alt="Simulations Plus, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/8a/1724680280.png" style="height:265px; width:574px" title="" />
Simulations Plus, Inc. price-consensus-chart | Simulations Plus, Inc. Quote
The company further announced the departure of Brett Howell, president of Quantitative Systems Pharmacology, and Michael Raymer, president of Clinical Simulations &amp; Medical Communications, who will leave after aiding in the transition.
Simulations Plus is a leading-edge developer of simulation software for pharmaceutical, chemical and biotechnology companies across the globe. The simulation software is used for drug discovery, development, research and regulatory submissions.
In the third quarter of fiscal 2024, the company&#39;s revenues increased 14% year over year to $18.5 million, primarily due to higher software revenues in the Clinical Pharmacology &amp; Pharmacometrics and Cheminformatics business units.
However, sales of the PBPK unit, part of the services segment, were down 10% as the temporary delays in acquiring client source data deferred the initiation of contracted projects. SLP has also opted to discontinue the quarterly cash dividend and redirect these funds towards growth initiatives to boost long-term shareholder value.
Currently, Simulations Plus carries a Zacks Rank #4 (Sell). Shares of the company have lost 19.4% compared with the sub-industry&#39;s growth of 24.7%.
</div>
&nbsp;
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/6f/75438.jpg?v=1950690958" />
Image Source: Zacks Investment Research
<h2>Stocks to Consider</h2>
Manhattan Associates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>), sporting a Zacks Rank #1 (Strong Buy) at present, has delivered an earnings surprise of 26.6%, on average, in the trailing four quarters. In the last reported quarter, MANH delivered an earnings surprise of 22.9%.
ANSYS, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>), carrying a Zacks Rank #2 (Buy) at present, has delivered an earnings surprise of 4.8%, on average, in three of the trailing four quarters. In the last reported quarter, ANSS delivered an earnings surprise of 28.9%. It has a long-term earnings growth expectation of 6.4%.
Adobe Inc., carrying a Zacks Rank #2 at present, has delivered an earnings surprise of 2.7%, on average, in the trailing four quarters. In the last reported quarter, ADBE delivered an earnings surprise of 2.1%. It has a long-term earnings growth expectation of 13%.
<a href="https://www.zacks.com/stock/news/2327227/simulations-plus-slp-restructures-business-unit-post-acquisitions?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2327227">To read this article on Zacks.com click here.</a>

Dividends

Simulations Plus Restructures Business Unit Post-Acquisitions

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 20 years by 12.35% on an annualized basis producing an average annual return of 20.77%. Currently, Manhattan Associates has a market capitalization of $15.91 billion. 
Buying $1000 In MANH: If an investor had bought $1000 of MANH stock 20 years ago, it would be worth $42,320.16 today based on a price of $259.74 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1724103011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Manhattan Associates 20 Years Ago Would Be Worth Today

Wix.com&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) shares have been performing well on the trading front, with a gain of 32.5% year to date compared with the S&amp;P 500 composite and sub-industry&#39;s growth of 16.2% and 1.8%, respectively.
The stock has gained 4.2% since announcing solid second-quarter 2024 results on Aug 7. The stock is still trading 8.7% below its 52-week high of $178.65, which makes it relatively affordable for investors.
Headquartered in Tel Aviv, Israel and founded in 2006, WIX is a cloud-based web development platform. It offers solutions that enable businesses, organizations, professionals and individuals to develop customized websites and application platforms and grow the companies&#39; online presence.
The company&#39;s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters with the average surprise being 29.8%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/36/74490.jpg?v=1273220810" />
Image Source: Zacks Investment Research
<h3>WIX Studio &amp; AI Strategy Propelling Growth</h3>
Increasing adoption of the product portfolio, especially various AI products and WIX Studio, has been driving WIX&#39;s performance. The addition of new features and enhancements to WIX Studio is driving its uptake. Management highlighted that the number of Studio accounts and rate of new Partners joining the Wix platform through Studio continues to better expectations.
The addition of new AI-powered offerings to its product portfolio is another tailwind. WIX is also focusing on embedding AI assistants across its platform and has released 17 AI business assistants so far.
In June 2024, Wix launched advanced AI creation capabilities for its mobile app builder. The initiative is set to empower users to effortlessly craft professional and fully customizable applications. By leveraging AI technology, it revolutionizes the way business apps for iOS and Android can be designed and altered.
The company also expanded the availability of its AI Website Builder in different languages. Besides English, AI Website Builder is now available to global users in French, German, Portuguese, Spanish, Italian, Japanese, Turkish and Korean. This initiative aids users in building websites in their preferred language.
WIX&#39;s second-quarter total revenues increased 12% year over year to $435.7 million and beat the Zacks Consensus Estimate of $433.6 million. Bookings of $458.4 million improved 15% year over year. Creative Subscriptions&#39; bookings increased 12% year over year to $329 million. Business Solutions&#39; bookings rose 24% to $129.4 million.
Partners revenues in the second quarter were $148.4 million, or 34% of total revenues, up 29% year over year. The increase was driven by market share gains resulting from the onboarding of new agencies and freelancers.
<h3>Outlook Revised</h3>
Continued strong momentum in the first half of 2024 led WIX to upgrade the outlook for bookings, revenues and free cash flow for the year.
Total bookings are expected between $1,802 million and $1,822 million, compared with a previous range of $1,796-$1,826 million.
Total revenues are now expected to be in the range of $1,747-$1,761 million (previous projection:&nbsp; $1,738 million to $1,761 million).
Free cash flow, excluding headquarters costs, is expected between $460 million and $470 million, or 26-27% of revenues in 2024. Earlier, free cash flow was expected in the range of $445-$455 million, or 26% of revenues.
<h3>Estimates Moving North</h3>
The estimates have also moved northward in the past 60 days. The Zacks Consensus Estimate for 2024 and 2025 earnings per share has increased 7.3% and 2.4%, respectively, reflecting analysts&#39; optimism.
The estimated figures for 2024 and 2025 EPS, $5.86 and $6.93, indicate a rise of 33.5% and 18.3%, respectively, from the prior-year actuals. The long-term earnings growth rate is 22.4%.
The Zacks Consensus Estimate for WIX&#39;s 2024 and 2025 revenues is pegged at $1.75 billion and $1.99 billion, respectively, which indicates growth of 12.4% and 13.2% from the year-ago levels.
<h3>Headwinds Persist</h3>
However, unfavorable foreign currency movement and weak global macroeconomic conditions are headwinds.
Increasing investments in product development, infrastructure and platform, along with stiff competition in the e-commerce marketplace, remain concerns for this Zacks Rank #3 (Hold) stock.
<h3>Stocks to Consider</h3>
Some better-ranked stocks worth consideration in the broader technology space are Badger Meter (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmi#NYSE">BMI</a>), Manhattan Associates (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>) and ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>). Badger Meter and Manhattan Associates sport a Zacks Rank #1 (Strong Buy) each, while ANSYS carries a Zacks Rank #2 (Buy), at present.
The Zacks Consensus Estimate for Badger Meter&#39;s 2024 EPS is pegged at $4.06, up 4.4% in the past 30 days. BMI&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 12.9%. The long-term earnings growth rate is 17.9%. Its shares have risen 26.1% in the past year.
The Zacks Consensus Estimate for ANSS&#39; 2024 earnings is pegged at $9.72, up 3.7% in the past 30 days. ANSS&#39; earnings beat the Zacks Consensus Estimate in three of the last four quarters while missing once, with the average surprise being 4.8%. Its shares have risen 12.1% in the past year.
The Zacks Consensus Estimate for MANH&#39;s 2024 EPS is pegged at $4.26. MANH&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 26.6%. The stock has surged 37.7% in the past year.
<a href="https://www.zacks.com/stock/news/2323236/wix-stock-soars-33-year-to-date-will-the-rally-continue?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2323236">To read this article on Zacks.com click here.</a>

WIX Stock Soars 33% Year to Date: Will the Rally Continue?

Onto Innovation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/onto#NYSE">ONTO</a>) shares have been performing well on the trading front, with a gain of 30.3% year to date compared with the S&amp;P 500 composite&#39;s and sub-industry&#39;s growth of 14.1% and 28.5%, respectively.
Solid financial performance has been aiding the stock&#39;s trajectory. The stock has gained 12% since announcing second-quarter fiscal 2024 results on Aug 8.
ONTO outpaced estimates in each of the trailing four quarters, with the average surprise being 6.6%.
The stock is trading down 16.7% from its 52-week high of $238.13, indicating further upside potential.
Headquartered in Wilmington, MA, Onto Innovation specializes in the design, development, manufacture and support of metrology and inspection tools primarily for semiconductor device fabricators, silicon wafer manufacturers and advanced packaging manufacturers in the semiconductor space.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/9f/74399.jpg?v=81156687" />
Image Source: Zacks Investment Research
<h3>Factors Driving Growth</h3>
Onto Innovation&#39;s performance is gaining from increasing demand for its Dragonfly inspection system. Its Dragonfly G3 platform integrates 2D and 3D technologies to identify yield-killing defects and compute features, which are important for advanced front-end and packaging technologies.
The system is witnessing strong adoption owing to higher demand for advanced packaging of AI computing devices.
In the last reported quarter, total revenues of $242.3 million beat the Zacks Consensus Estimate by 2.9%. The top line expanded 27.1% year over year. The uptick was largely driven by the expansion of pilot lines for high-performance computing, which incorporates cutting-edge gate-all-around transistor architecture and high-bandwidth memory to support the growing demand in the AI sector.
Revenues surpassed the high end of the company&#39;s guided range of $230-$240 million. Management highlighted record revenues of $164 million from its specialty and advanced packaging customers. This growth was driven by demand from the company&#39;s AI packaging customers.
ONTO secured more than $300 million in volume purchase agreements from two major customers. These agreements, which extend through 2025, pertain to investments in AI advanced packaging and gate-all-around technologies.
Healthy momentum in advanced nodes sales was driven by the success of ONTO&#39;s Atlas and Iris systems. These systems are pivotal in supporting emerging gate-all-around devices. 
In addition, ONTO bolstered its product portfolio with the introduction of the JetStep X500 lithography tool, specifically crafted for next-generation glass substrates used in panel-level packaging. The addition of these sensors will enable its users to collect important data needed to mature their process in a relatively shorter time.
The company remains focused on inventory reduction to boost cash-flow performance. Improvements in supply-chain initiatives are expected to drive margin performance.
For the third quarter, the management expects revenues in the range of $245-$255 million. For the second half, it now expects revenues to be 5-10% stronger than the first half of 2024.
ONTO expects revenues to gain from increasing investments in gate-all-around capacity, and capacity expansions by several high-bandwidth memory and logic packaging manufacturers in 2025.
<h3>Headwinds Persist</h3>
Nonetheless, weak global macro conditions, forex fluctuations and fierce competition are concerns for this Zacks Rank #3 (Hold) stock.
Increasing expenses is likely to weigh on the margin performance. For the third quarter of 2024, it expects operating expenses in the range of $64-$66 million amid higher research and development expenses.
<h3>A Look at Estimates</h3>
The Zacks Consensus Estimate for ONTO&#39;s 2024 and 2025 revenues is pegged at $968.9 million and $1.1 billion, respectively, indicating growth of 18.8% and 13.4% from the year-ago levels.
The consensus estimate for 2024 and 2025 EPS implies a rise of 37% and 22%, respectively, from the prior-year actuals to $5.11 and $6.24.
The consensus mark for 2024 EPS has increased 2%, in the past 90 days.
<h3>Stocks to Consider</h3>
Some better-ranked stocks worth consideration in the broader technology space are Badger Meter (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmi#NYSE">BMI</a>), Manhattan Associates (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>) and ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>). Badger Meter and Manhattan Associates sport a Zacks Rank #1 (Strong Buy) each, while ANSYS carries a Zacks Rank #2 (Buy), at present.
The Zacks Consensus Estimate for Badger Meter&#39;s 2024 EPS is pegged at $4.06, up 4.4% in the past 30 days. BMI&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 12.9%. The long-term earnings growth rate is 17.9%. Its shares have risen 17.1% in the past year.
The Zacks Consensus Estimate for ANSS&#39; 2024 earnings is pegged at $9.72, up 3.7% in the past 30 days. ANSS&#39; earnings beat the Zacks Consensus Estimate in three of the last four quarters while missing once, with the average surprise being 4.8%. Its shares have risen 7.7% in the past year.
The Zacks Consensus Estimate for MANH&#39;s 2024 EPS is pegged at $4.26. MANH&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 26.6%. The stock has surged 30.7% in the past year.
<a href="https://www.zacks.com/stock/news/2322399/onto-innovation-onto-soars-30-ytd-will-the-rally-last?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2322399">To read this article on Zacks.com click here.</a>

ONTO

Onto Innovation Soars 30% YTD: Will the Rally Last?

Itron&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itri#NASDAQ">ITRI</a>) shares have been performing well on the trading front, with a gain of 33.1% year to date compared with 19.2% and 2.5% growth of the S&amp;P 500 composite and the sub-industry, respectively.&nbsp;
The stock is down 16.4% from its 52-week high level of $113.07, reflecting further potential upside.
Headquartered in Liberty Lake, WA, Itron is one of the leading global suppliers of a wide range of standard, advanced and smart meters and meter communication systems. It also provides networks and communication modules, software, services and sensors for the effective management of electricity, gas and water resources for its consumers.
With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) stock appears to be a solid investment option at present.
Apart from a favorable rank, ITRI has a Growth Score of B. Per Zacks&#39; proprietary methodology, stocks with a combination of a Zacks Rank #1 (Strong Buy) or 2 and&nbsp; a Growth Score of A or B offer solid investment opportunities.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/90/74132.jpg?v=1310954533" />
Image Source: Zacks Investment Research
The company&#39;s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters with an average surprise of 57%.
&nbsp;
<h3>Steady Demand Trends</h3>
Steady market demand remains the primary catalyst. The company recently posted its second-quarter 2024 results wherein revenues of $609 million beat the Zacks Consensus Estimate of $600 million. The top line expanded 13% (up 13% at constant currency) year over year.
Successful operational execution and conversion of previously constrained revenues aided the top-line growth. Itron&#39;s bookings were $447 million, and its backlog amounted to $4.1 billion at the end of the reported quarter.
Networked Solutions&#39; revenues totaled $412.7 million (67.8%), up 14% year over year, driven by current and new project deployments. Outcomes&#39; revenues of $77.8 million (12.8%) increased 16% on a year-over-year basis attributed to higher recurring and one-time services revenues.
Momentum in the Grid Edge Intelligence platform augurs well. The platform&#39;s growth is being driven by various factors, including data center-related demand growth, reindustrialization and production localization, as well as electrification of transportation and homes. Itron added that automation of water infrastructure, safety applications for gas customers and the digitalization of its operations were other growth drivers.
Also, the acquisition of Elpis Squared expanded the Grid Edge Intelligence platform&#39;s solutions. Management noted that its customers are increasingly deploying new digital technology and non-wires grid solutions. This represents a strong opportunity for ITRI.
<h3>Solid Outlook</h3>
Itron anticipates 2024 bookings to result in a book-to-bill ratio of at least 1:1.
For the third quarter of 2024, ITRI expects revenues to be between $590 million and $600 million. Non-GAAP EPS is anticipated to be in the range of $1.10-$1.20. The Zacks Consensus Estimate for both top and bottom lines is pegged at $597 million and $1.10 per share.
The company has revised its full-year revenue outlook for 2024. Management now projects revenues to be between $2.385 billion and $2.415 billion compared with earlier guidance of $2.275 to $2.375 billion.
Non-GAAP EPS is currently estimated in the $4.45-$4.65 band compared with of $3.40-$3.80 projected in February 2024.
<h3>Estimates Northward Bound</h3>
The Zacks Consensus Estimate for ITRI&#39;s 2024 and 2025 revenues is pegged at $2.41 billion and $2.5 billion, respectively, indicating growth of 10.8% and 3.8% from the year-ago levels.
The consensus estimated figures for 2024 and 2025 EPS are expected to rise 33.3% and 3.6% from the prior-year actuals of $4.48 and $4.64, respectively.
The figures of consensus mark for 2024 and 2025 EPS have increased 12% and 5.9%, respectively, in the past 60 days, reflecting analysts&#39; optimism.
ITRI&#39;s long-term earnings growth rate is pegged at 26%.
<h3>Headwinds Persist</h3>
However, rising operating expenses and stiff competition amid a soft macroeconomic backdrop remain concerns.
In the second quarter of 2024, non-GAAP operating expenses of $141.1 million jumped 6.6% year over year due to higher sales and general and administrative costs. These factors might exert pressure on the margins, at least in the near term.
Itron also has a leveraged balance sheet. As of Jun 30, 2024, the company&#39;s cash and cash equivalents totaled $920.6 million. Long-term debt at the end of the second-quarter 2024 was $1.24 billion.
<h3>Other Stocks to Consider</h3>
Other top-ranked stocks worth consideration in the broader technology space are Badger Meter (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bmi#NYSE">BMI</a>), Manhattan Associates (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/manh#NASDAQ">MANH</a>) and ANSYS (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anss#NASDAQ">ANSS</a>). Badger Meter and Manhattan Associates sport a Zacks Rank #1 each, while ANSYS carries a Zacks Rank #2 at present.
The Zacks Consensus Estimate for Badger Meter&#39;s 2024 EPS is pegged at $4.06, up 4.4% in the past 30 days. BMI&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, the average surprise being 12.9%. The long-term earnings growth rate is 17.9%. Its shares have risen 12.5% in the past year.
The Zacks Consensus Estimate for ANSS&#39; 2024 earnings is pegged at $9.72, up 3.7% in the past 30 days. ANSS&#39; earnings beat the Zacks Consensus Estimate in three of the last four quarters while missing once, with the average surprise being 4.8%. Its shares have risen 3.3% in the past year.
The Zacks Consensus Estimate for MANH&#39;s 2024 EPS is pegged at $4.26. MANH&#39;s earnings beat the Zacks Consensus Estimate in each of the last four quarters, with the average surprise being 26.6%. The stock has surged 28.4% in the past year.
<a href="https://www.zacks.com/stock/news/2321144/itron-itri-stock-up-33-1-in-a-year-will-the-rally-continue?cid=CS-BENZ-FT-analyst_blog|price_surge_/_plunge-2321144">To read this article on Zacks.com click here.</a>

Guidance

ITRI

Itron Stock Up 33.1% in a Year: Will the Rally Continue?

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 15 years by 18.71% on an annualized basis producing an average annual return of 30.44%. Currently, Manhattan Associates has a market capitalization of $15.43 billion. 
Buying $1000 In MANH: If an investor had bought $1000 of MANH stock 15 years ago, it would be worth $54,016.75 today based on a price of $252.00 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722618039_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Manhattan Associates 15 Years Ago Would Be Worth Today

Manhattan Associates's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NYSE">MANH</a>) short percent of float has risen 20.74% since its last report. The company recently reported that it has 1.76 million shares sold short, which is 3.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Manhattan Associates Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722525311_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Manhattan Associates has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Manhattan Associates's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Manhattan Associates's peer group average for short interest as a percentage of float is 3.33%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(MANH) - Analyzing Manhattan Associates's Short Interest

These eleven large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares escalated 33.37% after the company announced <a href="https://www.benzinga.com//node/39880836" target="_blank" rel="noreferrer noopener">a private placement financing</a>.</li>
<li>Avantor Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) stock gained 21.62% in the last week after it was announced the stock will join the S&amp;P MidCap 400. Also, it reported better-than-expected Q2 earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) stock jumped 17.73% after the company reported better-than-expected&nbsp;Q2&nbsp;earnings and <a href="https://www.benzinga.com//node/39942622" target="_blank" rel="noreferrer noopener">increased FY 2024&nbsp;guidance</a>.</li>
<li>Manhattan Associates Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) stock upped 17.02% after reporting better-than-expected Q2 financial results. Several analysts raised their <a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on the stock</a>.</li>
<li>Molina Healthcare Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) shares increased 15.53% following <a href="https://www.benzinga.com//node/39942485" target="_blank" rel="noreferrer noopener">better-than-expected&nbsp;Q2&nbsp;earnings</a>.</li>
<li>First Citizens BancShares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) shares increased 15.15% after the company reported better-than-expected earnings.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) stock increased 13.02% after the company reported better-than-expected&nbsp;Q2&nbsp;financial results, and the company raised its FY24&nbsp;guidance&nbsp;above estimates and issued&nbsp;Q3&nbsp;guidance&nbsp;above estimates. Also, the company announced it a<a href="https://www.benzinga.com//node/39934114" target="_blank" rel="noreferrer noopener">uthorized a&nbsp;$1.5 billion&nbsp;share buyback</a>.</li>
<li>CBRE Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) shares gained 12.99% in the last week after the company raised its 2024 guidance. Several analysts raised their <a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecasts on </a><a href="https://www.benzinga.com/quote/CBRE/analyst-ratings" target="_blank" rel="noreferrer noopener">t</a><a href="https://www.benzinga.com/quote/MANH/analyst-ratings" target="_blank" rel="noreferrer noopener">he stock</a>.</li>
<li>Thermo Fisher Scientific Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) stock rose 12.63% in the last week. The company raised <a href="https://www.benzinga.com//node/39930516" target="_blank" rel="noreferrer noopener">its annual outlook</a>.</li>
<li>Danaher Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) stock gained 11.30% are trading higher after the company reported better-than-expected Q2 earnings.</li>
<li>Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) stock grew 10.72% on positive analyst <a href="https://www.benzinga.com//node/39941283" target="_blank" rel="noreferrer noopener">ratings and strong Q2 results</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/07/40001668/ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-other">Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 10 years by 13.22% on an annualized basis producing an average annual return of 24.11%. Currently, Manhattan Associates has a market capitalization of $15.12 billion. 
Buying $1000 In MANH: If an investor had bought $1000 of MANH stock 10 years ago, it would be worth $8,234.71 today based on a price of $246.87 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1722004262_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $8,200 Today

Shares of General Dynamics Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) fell sharply during Wednesday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39934099/general-dynamics-hits-high-revenue-but-faces-earnings-hiccup-in-q2-details">second-quarter EPS results</a>.
Revenue for the quarter increased 18% year-over-year to $11.976 billion, beating the consensus of $11.438 billion. EPS of $3.26 (up 20.7% YoY) missed the consensus of $3.29, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
General Dynamics shares declined 5.2% to $279.26 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>NuZee, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) jumped 192% to $3.01.</li>
<li>Dermata Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) rose 142.4% to $3.0799 after falling over 22% on Tuesday.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) surged 134% to $0.0609.</li>
<li>Bone Biologics Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBLG#NASDAQ">BBLG</a>) gained 86% to $2.3300.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREV#NASDAQ">CREV</a>) gained 74.5% to $10.82.</li>
<li>Pieris Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIRS#NASDAQ">PIRS</a>) jumped 73.4% to $13.77 after the company announced that the company entered into a definitive merger agreement with Palvella Therapeutics.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) gained 50% to $0.60 after licensing partner Pfizer&#8217;s Phase 3 AFFINE trial evaluating giroctocogene fitelparvovec met its primary endpoint.</li>
<li>Alpha Teknova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKNO#NASDAQ">TKNO</a>) gained 28% to $3.2212.</li>
<li>KORE Group Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NASDAQ">KORE</a>) gained 21.8% to $2.84.</li>
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) rose 20.5% to $6.87 after reporting unaudited 2024 second quarter and first half financial results.</li>
<li>PROG Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRG#NYSE">PRG</a>) climbed 20.4% to $41.71 after the company reported better-than-expected second-quarter financial results. Also, the company raised its FY24 guidance above estimates.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) gained 19.4% to $94.69. The company on Monday announced a private placement financing.</li>
<li>Silynxcom Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYNX#NYSE">SYNX</a>) rose 18.4% to $3.71. Silynxcom received $815,000 in orders from Israel Defense Forces since July 2024.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares gained 16.4% to $1.0009 after the company announced steady progress in its due diligence efforts in its proposed reverse merger with COVIRIX Medical and anticipates completion by the end of August 2024.</li>
<li>Flex Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) gained 10.9% to $32.96 after the company reported better-than-expected second-quarter financial results.</li>
<li>Manhattan Associates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) climbed 10.5% to $249.78 after the company reported better-than-expected second-quarter financial results.</li>
<li>Group 1 Automotive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) gained 9.6% to $333.95 after the company reported better-than-expected second-quarter adjusted EPS results.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) rose 9.2% to $113.18 after the company reported second-quarter financial results.</li>
<li>Allarity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) gained 8.7% to $0.1809. Allarity Therapeutics revealed on Monday it received a "Wells Notice" from the U.S. Securities and Exchange Commission (SEC).</li>
<li>Mattel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) gained 7.9% to $18.61 after the company reported better-than-expected second-quarter adjusted EPS results.</li>
<li>Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) shares surged 7.5% to $113.33 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.</li>
<li>Alkermes plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>) gained 7% to $26.69 after the company reported better-than-expected <a>second-quarter </a>financial results.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) gained 6.8% to $148.17 after the company reported better-than-expected second-quarter financial results and the company and raised its FY24 guidance above estimates. Also, the company announced it authorized a $1.5 billion share buyback.</li>
<li>AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) gained 3.1% to $18.78 following second-quarter earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares dipped 74.4% to $1.27. Azitra announced the pricing of $10.0 million public offering.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) fell 58% to $2.42.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) dipped 43.8% to $4.25.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) fell 37.2% to $2.6199 after the company announced the pricing of a $2 million public offering of 469,340 common shares at $4.24 a share.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) dipped 34.2% to $0.1414.</li>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) declined 26.9% to $57.46 after the company reported worse-than-expected quarterly financial results. Also, the company issued its FY25 EPS guidance below estimates.</li>
<li>Conn&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CONN#NASDAQ">CONN</a>) shares fell 26.7% to $0.3717 as the company announced plans to close 71 locations across 13 states.</li>
<li>Vintage Wine Estates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VWE#NASDAQ">VWE</a>) fell 24.5% to $0.0868 after the company announced bankruptcy filing and voluntary delisting and SEC deregistration.</li>
<li>Snow Lake Resources Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) declined 24.2% to $0.7350 after the company issued an update on Black Lake Uranium Project.</li>
<li>AtlasClear Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NASDAQ">ATCH</a>) shares declined 23.8% to $0.4228 after gaining 11% on Tuesday.</li>
<li>Verastem, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) shares fell 22.7% to $2.7750 after the company reported pricing of $55.0 million public offering of common stock, warrants and pre-funded warrants.</li>
<li>Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) dipped 17.8% to $10.75 after the Phase 2 KINETIC 2 study of SAGE-324 did not demonstrate a statistically significant dose-response relationship on the primary endpoint.</li>
<li>Hawaiian Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HA#NASDAQ">HA</a>) dipped 13% to $11.33.</li>
<li>SFL Corporation Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFL#NYSE">SFL</a>) shares fell 12.3% to $12.23 after the company announced an offering of 8 million common shares.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares fell 12% to $216.78. Tesla reported weaker-than-expected earnings for its second quarter, while sales topped estimates. The company reported second-quarter deliveries of 443,956 vehicles and production of 410,831 vehicles, down 5% and 14% year-over-year, respectively.</li>
<li>Karooooo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) dipped 11.3% to $31.90 as the company announced the launch of secondary public offering of ordinary shares.</li>
<li>Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) fell 10.2% to $15.29.</li>
<li>Kanzhun Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) dipped 9.5% to $14.41.</li>
<li>Chijet Motor Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJET#NASDAQ">CJET</a>) fell 9.3% to $4.61 after jumping 55% on Tuesday.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) dipped 9.1% to $25.14 after the company announced a primary offering of 25 million shares.</li>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares declined 8.8% to $4.2150 after the company announced the departure of CCO Anil Kapur.</li>
<li>The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) fell 8.4% to $92.45.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) fell 8.2% to $56.97.</li>
<li>Deutsche Bank Aktiengesellschaft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) shares fell 8% to $15.69 following second-quarter earnings.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) declined 8% to $14.25.</li>
<li>Weatherford International plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) dipped 7.6% to $123.57 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Roper Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NYSE">ROP</a>) fell 7.4% to $532.08 after the company reported worse-than-expected second-quarter sales results and issued third-quarter adjusted EPS guidance below estimates.</li>
<li>Volato Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#NYSE">SOAR</a>) shares fell 7.1% to $0.5479 after gaining around 23% on Tuesday.</li>
<li>Fortive Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) fell 6.9% to $71.36 after the company reported worse-than-expected second-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) fell 5.5% to $367.84 after Piper Sandler downgraded the stock from an Overweight to Neutral and lowered its price target from $494 to $404.</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) shares declined 4.1% to $174.29. Alphabet reported upbeat earnings and sales results for its second quarter on Tuesday. The company also announced a cash dividend of 20 cents per share to be paid on Sept.16 to shareholders of record as of Sept. 9.</li>
<li>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) shares fell 3.8% to $254.72 following third-quarter results.</li>
</ul>
Now Read This:  
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39932485/jim-cramer-calls-axsome-a-double-or-nothing-stock-says-sap-is-incredible">Cramer Calls Axsome A &#8216;Double Or Nothing Stock,&#8217; Says SAP Is &#8216;Incredible</a><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39932485/jim-cramer-calls-axsome-a-double-or-nothing-stock-says-sap-is-incredible">&#8216;</a></li>
</ul>

Intraday Update

ALGM

ALKS

ALLR

ATCH

ATPC

AZTR

BBLG

BLCO

CJET

CONN

CREV

DRMA

FLEX

GERN

GOOGL

KARO

KORE

LITM

NAAS

NIVF

NUWE

NUZE

Next Technology Holding Inc. - Ordinary Shares

NXTT

PIRS

ROKU

SAGE

SGMO

SLNA

SOAR

SYNX

TKNO

TSLA

ULTA

VSTM

Vintage Wine Estates, Inc. - Common Stock

WFRD

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

D.A. Davidson analyst Gil Luria reiterated a Buy rating on Manhattan Associates (MANH – Research Report) today. The company's shares closed yesterd...

D.A. Davidson Reaffirms Their Buy Rating on Manhattan Associates (MANH)

SPS Commerce Beats Q2 Estimates, But Revenue Growth Is A Concern

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Manhattan Associates (MANH – Research Report) and In...

Analysts Offer Insights on Technology Companies: Manhattan Associates (MANH) and Infineon Technologies AG (OtherIFNNF)

Invesco Small Cap Growth Fund Q2 2024 Review

Baird Q2 2024 Small/Mid Cap Growth Equity Fund Commentary

Manhattan Associates Q2: Balancing Record Growth With Valuation Pressures

Baird Q2 2024 Mid Cap Growth Equity Fund Commentary

Sell The Highs: Manhattan Associates' Overvaluation Points To A Market Correction

Stock Picks From Seeking Alpha's August 2024 New Analysts

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Belden (BDC – Research Report), Manhattan Associates...

Comments

Manhattan Associates

뉴스

에 대한 최신 뉴스 Manhattan Associates (NASDAQ:MANH) 주식

일요일, 7월 28, 2024

월요일, 4월 29, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌